News

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
The Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
A young woman details her experience with the newly available weight loss medication.
Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...